TP53 and acute myeloid leukemia: However, the fraction of annexin-V-positive cells was approximately 10% in the TP53mut THP-1 cells and did not increase with a higher concentration of venetoclax (Figure 1b), suggesting that TP53 mutation is one of the molecular abnormalities associated with venetoclax resistance in AML cells.